Publications by authors named "Geraldine Teppaz"

Claim this Profile
F
First-in-Human Study in Healthy Subjects with the Noncytotoxic Monoclonal Antibody OSE-127, a Strict Antagonist of IL-7Rα.
Nicolas Poirier, Irène Baccelli, Lyssia Belarif, Riad Abès, Géraldine Teppaz

J Immunol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CLEC-1 is a death sensor that limits antigen cross-presentation by dendritic cells and represents a target for cancer immunotherapy.
Marion Drouin, Javier Saenz, Vanessa Gauttier, Berangere Evrard, Geraldine Teppaz

Sci Adv· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selective SIRPα blockade reverses tumor T cell exclusion and overcomes cancer immunotherapy resistance.
Vanessa Gauttier, Sabrina Pengam, Justine Durand, Kevin Biteau, Caroline Mary, Géraldine Teppaz

J Clin Invest· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SIRPα/CD47 axis controls the maintenance of transplant tolerance sustained by myeloid-derived suppressor cells.
Sabrina Pengam, Justine Durand, Claire Usal, Vanessa Gauttier, Nahzli Dilek, Géraldine Teppaz

Am J Transplant· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IL-15 Trans-Signaling with the Superagonist RLI Promotes Effector/Memory CD8+ T Cell Responses and Enhances Antitumor Activity of PD-1 Antagonists.
Mélanie Desbois, Pauline Le Vu, Clélia Coutzac, Elie Marcheteau, Coralie Béal, Géraldine Teppaz

J Immunol· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Highly potent anti-CD20-RLI immunocytokine targeting established human B lymphoma in SCID mouse.
Marie Vincent, Géraldine Teppaz, Laurie Lajoie, Véronique Solé, Anne Bessard

MAbs· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor targeting of the IL-15 superagonist RLI by an anti-GD2 antibody strongly enhances its antitumor potency.
Marie Vincent, Anne Bessard, Denis Cochonneau, Géraldine Teppaz, Véronique Solé

Int J Cancer· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toward efficient drug screening by homogeneous assays based on the development of new fluorescent vasopressin and oxytocin receptor ligands.
Laura Albizu, Géraldine Teppaz, René Seyer, Hervé Bazin, Hervé Ansanay

J Med Chem· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis